Sun Pharma Showcases Major Research Advancements at 2026 AAD Annual Meeting At the 2026 AAD Annual Meeting, Sun Pharma presents 14 abstracts, showcasing advancements in the treatment of alopecia areata, psoriasis, and acne. The company emphasizes patient-centered care through meaningful scientific data.

Sun Pharma Showcases Major Research Advancements at 2026 AAD Annual Meeting #India #Mumbai #ILUMYA #Sun_Pharma #LEQSELVI

#sun-pharma #leqselvi #hair-loss-drug #hair-loss #androgenetic-alpecia #anti-baldness #patent-settlement #patent-litigation #pharmaceutical-industry #biopharmaceuticals #incyte-corp #us-japan-compliance #drug-launch #market-entry #india-to-us #top-drugmaker

Sun Pharma Launches LEQSELVI for Severe Alopecia Areata Treatment in the U.S. Sun Pharmaceutical Industries has announced the U.S. launch of LEQSELVI, a new treatment option for adults with severe alopecia areata. This breakthrough offers hope for effective hair regrowth.

Sun Pharma Launches LEQSELVI for Severe Alopecia Areata Treatment in the U.S. #United_States #Princeton #Alopecia_Areata #Sun_Pharma #LEQSELVI